Wellthy Therapeutics targets threefold growth in revenue over next 2-3 yrs

Wellthy Therapeutics, a start-up working in the area of digital healthcare solutions, has now shifted focus towards rapid revenue growth, after spending three years (since inception) on validating its solutions through real world studies.

Backed by Cipla and Manipal Group’s Ranjan Pai, Wellthy is a digital personal diabetes coach that uses artificial intelligence (AI) to facilitate behavioural change and improve health literacy among patients, in collaboration with hospitals, doctors, medical device makers, and insurance firms.

The solutions are offered to the end-consumer only through these healthcare partners, with the objective being to mainly address issues in chronic disease management.

For instance, the firm